Pompili E, Pantanali F, Deli R, De Renzis G
Istituto di Anatomia Umana, Università Cattolica Sacro Cuore-Roma.
Minerva Stomatol. 1995 Sep;44(9):397-402.
The calpains-calpastatin system (calcium-activated neutral proteases and endogenous inhibitor) seems to be, in the skeletal muscle, a fine enzymatic system of myofibrillar turnover regulation, in normal as well as pathological conditions (for ex., dystrophic muscle). The purpose of the research is to establish in qualitative and quantitative terms whether the level of calpastatin can evidence differences between a muscle in normal activity conditions and one having dysfunctional alterations experimentally induced. So the masseter muscle of rabbit in normal conditions and with experimentally modified occlusal plane has been used. Our results confirm the presence of the 68 KDa calpastatin in the masseter muscle. The presence of the inhibitor in the same subcellular structures in which the calpains have been detected (myofibrillars, sarcolemma, endomysial connective) has been confirmed. Finally, variations in calpastatin amount in the muscle of animals experimentally treated with respect to the controls have been found. Thus, calpastatin seems to act as a marker of muscle dysfunctions connected to occlusal plane alteration and to loss of vertical dimention.
钙蛋白酶-钙蛋白酶抑制蛋白系统(钙激活中性蛋白酶和内源性抑制剂)在骨骼肌中似乎是一个精细的酶系统,在正常及病理状况(如营养不良性肌肉)下调节肌原纤维的更新。本研究的目的是从定性和定量方面确定钙蛋白酶抑制蛋白的水平能否显示正常活动状态下的肌肉与实验诱导功能失调改变的肌肉之间的差异。因此,我们使用了正常条件下以及实验性改变咬合平面的家兔咬肌。我们的结果证实了咬肌中存在68 kDa的钙蛋白酶抑制蛋白。已证实在检测到钙蛋白酶的相同亚细胞结构(肌原纤维、肌膜、肌内膜结缔组织)中存在该抑制剂。最后,发现实验处理动物的肌肉中钙蛋白酶抑制蛋白的量相对于对照组有所变化。因此,钙蛋白酶抑制蛋白似乎可作为与咬合平面改变及垂直维度丧失相关的肌肉功能障碍的标志物。